Could Wiley’s (WLY) CPA Exam Content Integration Point to a Stronger Digital Learning Growth Story?

• On August 5, 2025, Gleim Exam Prep announced a partnership with Wiley to launch the Gleim Kieso Course Companion, integrating Gleim's CPA review resources with Wiley's Kieso "Intermediate Accounting" and WileyPLUS platform for classroom and CPA exam preparation.
• This collaboration brings over 460 CPA FAR multiple-choice questions and more than 200 exam-quality simulations directly into academic settings, creating a seamless bridge between traditional coursework and career-readiness for accounting students nationwide.
• We'll take a look at how direct CPA exam content integration with WileyPLUS may reinforce Wiley's position in digital learning and recurring revenue streams.

Uncover the next big thing with financially sound penny stocks that balance risk and reward.

John Wiley & Sons Investment Narrative Recap

For shareholders in John Wiley & Sons, the core investment case centers on the company’s ability to remain essential in digital learning and recurring content delivery, while defending its margins from competitive and structural headwinds. The recent Wiley-Gleim partnership integrates trusted CPA prep content directly into WileyPLUS, a move that may modestly reinforce its position in digital learning but does not materially impact the most important near-term catalyst: the expansion of AI and data-driven offerings. However, it does little to address the major risk of pricing pressure on traditional publishing revenues.

Of recent announcements, Wiley’s July partnership with Anthropic to integrate AI tools alongside peer-reviewed research stands out. This move is more directly relevant to short-term strategic goals, as it supports expanding the company’s high-margin, recurring revenue through advanced digital and AI-based offerings, reinforcing its most important catalyst.

On the other hand, a key source of uncertainty for investors remains the shifting economics of academic publishing and the risk of margin compression if open access models...

Read the full narrative on John Wiley & Sons (it's free!)

John Wiley & Sons' narrative projects $1.8 billion in revenue and $266.1 million in earnings by 2028. This requires 1.5% yearly revenue growth and a $181.9 million earnings increase from $84.2 million today.

Uncover how John Wiley & Sons' forecasts yield a $60.00 fair value, a 49% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community estimate Wiley’s fair value between US$30.43 and US$60, showing nearly twofold differences in outlook. With pressure on traditional publishing revenues still looming large, it is clear you have a broad range of views to consider.

Explore 3 other fair value estimates on John Wiley & Sons - why the stock might be worth as much as 49% more than the current price!

Build Your Own John Wiley & Sons Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your John Wiley & Sons research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
• Our free John Wiley & Sons research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate John Wiley & Sons' overall financial health at a glance.

Ready For A Different Approach?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com